Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics

Zhang, 2012, Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination, Schizophr Res, 138, 8, 10.1016/j.schres.2012.04.006 Bi, 2012, Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice, J Neurochem, 123, 14, 10.1111/j.1471-4159.2012.07883.x Chandran, 2012, Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice, Neuroscience, 202, 446, 10.1016/j.neuroscience.2011.10.051 Kimoto, 2011, Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures, Prog Neuropsychopharmacol Biol Psychiatry, 35, 1950, 10.1016/j.pnpbp.2011.07.011 Wang, 2010, Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain, Schizophr Res, 119, 164, 10.1016/j.schres.2010.02.1068 Potkin, 2013, Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole, Curr Med Res Opin, 29, 1241, 10.1185/03007995.2013.821973 Ren, 2013, Improving myelin/oligodendrocyte-related dysfunction: A new mechanism of antipsychotics in the treatment of schizophrenia?, Int J Neuropsychopharmacol, 16, 691, 10.1017/S1461145712001095 Selemon, 1999, Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure, Biol Psychiatry, 46, 161, 10.1016/S0006-3223(99)00113-4 Konopaske, 2008, Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys, Biol Psychiatry, 63, 759, 10.1016/j.biopsych.2007.08.018 Narayan, 2009, Evidence for disruption of sphingolipid metabolism in schizophrenia, J Neurosci Res, 87, 278, 10.1002/jnr.21822 Bartzokis, 2009, In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia, Schizophr Res, 113, 322, 10.1016/j.schres.2009.06.014 Bartzokis, 2011, Neuroglialpharmacology: White matter pathophysiologies and psychiatric treatments, Front Biosci, 16, 2695, 10.2741/3881 Szeszko, 2014, White matter changes associated with antipsychotic treatment in first-episode psychosis, Neuropsychopharmacology, 39, 1324, 10.1038/npp.2013.288 Wang, 2013, White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment, Psychol Med, 43, 2301, 10.1017/S0033291713000238 Luck, 2011, Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: A DTI-tractography study, J Psychiatr Res, 45, 369, 10.1016/j.jpsychires.2010.07.007 Reis Marques, 2014, White matter integrity as a predictor of response to treatment in first episode psychosis, Brain, 137, 172, 10.1093/brain/awt310 Garver, 2008, Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia, Int J Neuropsychopharmacol, 11, 49, 10.1017/S1461145707007730 Andreasen, 2011, Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia, Biol Psychiatry, 70, 672, 10.1016/j.biopsych.2011.05.017 Ho, 2011, Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia, Arch Gen Psychiatry, 68, 128, 10.1001/archgenpsychiatry.2010.199 Andreasen, 2013, Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: A prospective longitudinal MRI study, Am J Psychiatry, 170, 609, 10.1176/appi.ajp.2013.12050674 Molina, 2005, Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia, Schizophr Res, 80, 61, 10.1016/j.schres.2005.07.031 Girgis, 2006, Risperidone in first-episode psychosis: A longitudinal, exploratory voxel-based morphometric study, Schizophr Res, 82, 89, 10.1016/j.schres.2005.10.019 Szeszko, 2012, Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia, Schizophr Bull, 38, 569, 10.1093/schbul/sbq126 Poeppl, 2014, Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia, Int J Neuropsychopharmacol, 17, 833, 10.1017/S1461145713001739 Thompson, 2008, Time-lapse mapping of cortical changes in schizophrenia with different treatments, Cereb Cortex, 19, 1107, 10.1093/cercor/bhn152 Vita, 2015, The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: Does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies, Biol Psychiatry, 78, 403, 10.1016/j.biopsych.2015.02.008 Bartzokis, 2012, Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia, Schizophr Res, 140, 122, 10.1016/j.schres.2012.06.036 Subotnik, 2015, Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia. A randomized clinical trial, JAMA Psychiatry, 72, 822, 10.1001/jamapsychiatry.2015.0270 Subotnik, 2011, Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia, Am J Psychiatry, 168, 286, 10.1176/appi.ajp.2010.09010087 Lieberman, 1993, Time course and biologic correlates of treatment response in first-episode schizophrenia, Arch Gen Psychiatry, 50, 369, 10.1001/archpsyc.1993.01820170047006 Robinson, 2004, Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder, Am J Psychiatry, 161, 473, 10.1176/appi.ajp.161.3.473 Nuechterlein, 2006, Classifying episodes in schizophrenia and bipolar disorder: Criteria for relapse and remission applied to recent-onset samples, Psychiatry Res, 144, 153, 10.1016/j.psychres.2004.04.018 Kane, 1988, Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine, Arch Gen Psychiatry, 45, 789, 10.1001/archpsyc.1988.01800330013001 Lieberman, 2001, Longitudinal study of brain morphology in first episode schizophrenia, 49, 487 Lieberman, 2001, The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches, Biol Psychiatry, 50, 884, 10.1016/S0006-3223(01)01303-8 Lieberman, 2006, Neurobiology and the natural history of schizophrenia, J Clin Psychiatry, 67, e14, 10.4088/JCP.1006e14 Agid, 2013, Antipsychotic response in first-episode schizophrenia: Efficacy of high doses and switching, Eur Neuropsychopharmacol, 23, 1017, 10.1016/j.euroneuro.2013.04.010 Emsley, 2013, Comparison of treatment response in second-episode versus first-episode schizophrenia, J Clin Psychopharmacol, 33, 80, 10.1097/JCP.0b013e31827bfcc1 Benes, 1994, Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood, Arch Gen Psychiatry, 51, 477, 10.1001/archpsyc.1994.03950060041004 Bartzokis, 2002, Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation, Neuropsychopharmacology, 27, 672, 10.1016/S0893-133X(02)00364-0 Davis, 2003, White matter changes in schizophrenia: Evidence for myelin-related dysfunction, Arch Gen Psychiatry, 60, 443, 10.1001/archpsyc.60.5.443 Bartzokis, 2004, Quadratic trajectories of brain myelin content: Unifying construct for neuropsychiatric disorders, Neurobiol Aging, 25, 49, 10.1016/j.neurobiolaging.2003.08.001 Miller, 2012, Prolonged myelination in human neocortical evolution, Proc Natl Acad Sci U S A, 109, 16480, 10.1073/pnas.1117943109 Kemper, 1994, Neuroanatomical and neuropathological changes during aging and dementia, 3 Bartzokis, 2001, Age-related changes in frontal and temporal lobe volumes in men: A magnetic resonance imaging study, Arch Gen Psychiatry, 58, 461, 10.1001/archpsyc.58.5.461 Bartzokis, 2012, Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments, Neuropharmacology, 62, 2137, 10.1016/j.neuropharm.2012.01.015 Bartzokis, 2003, Dysregulated brain development in adult men with schizophrenia: A magnetic resonance imaging study, Biol Psychiatry, 53, 412, 10.1016/S0006-3223(02)01835-8 Vostrikov, 2007, Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders, Schizophr Res, 94, 273, 10.1016/j.schres.2007.04.014 Vostrikov, 2011, Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders, Schizophr Res Treat, 2011, 174689 Hof, 2002, Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia, Neurochem Res, 27, 1193, 10.1023/A:1020981510759 Uranova, 2004, Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium, Schizophr Res, 67, 269, 10.1016/S0920-9964(03)00181-6 Ho, 2003, Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia, Arch Gen Psychiatry, 60, 585, 10.1001/archpsyc.60.6.585 Whitford, 2007, Volumetric white matter abnormalities in first-episode schizophrenia: A longitudinal, tensor-based morphometry study, Am J Psychiatry, 164, 1082, 10.1176/ajp.2007.164.7.1082 Cocchi, 2009, Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia, Schizophr Res, 115, 163, 10.1016/j.schres.2009.09.009 Bartzokis, 2003, Biological underpinnings of treatment resistance in schizophrenia: An hypothesis, Psychopharmacol Bull, 37, 5 Bartzokis, 2005, Reduced intracortical myelination in schizophrenia, Am J Psychiatry, 162, 1229, 10.1176/appi.ajp.162.6.1229-a O’Brien, 1965, Lipid composition of the normal human brain: Gray matter, white matter, and myelin, J Lipid Res, 6, 537, 10.1016/S0022-2275(20)39619-X Rouser, 1972, Lipids in the nervous system of different species as a function of age: Brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: Regulatory mechanisms and membrane structure, Adv Lipid Res, 10, 261, 10.1016/B978-0-12-024910-7.50013-0 Saher, 2005, High cholesterol level is essential for myelin membrane growth, Nat Neurosci, 8, 468, 10.1038/nn1426 Koenig, 1991, Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain, Magn Reson Med, 20, 285, 10.1002/mrm.1910200210 Valk, 1989 van der Knaap, 1990, MR imaging of the various stages of normal myelination during the first year of life, Neuroradiology, 31, 459, 10.1007/BF00340123 Barkovich, 1992, Formation, maturation, and disorders of white matter, AJNR Am J Neuroradiol, 13, 447 Miot-Noirault, 1997, T2 relaxation time as a marker of brain myelination: Experimental MR study in two neonatal animal models, J Neurosci Methods, 72, 5, 10.1016/S0165-0270(96)00148-3 Beasley, 2009, Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder, Schizophr Res, 115, 156, 10.1016/j.schres.2009.09.028 Schmitt, 2009, Stereologic investigation of the posterior part of the hippocampus in schizophrenia, Acta Neuropathol, 117, 395, 10.1007/s00401-008-0430-y Uranova, 2011, Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study, Schizophr Res Treat, 2011, 325789 Kraepelin, 1919 Nuechterlein, 2011, Neurocognitive predictors of work outcome in recent-onset schizophrenia, Schizophr Bull, 37, S33, 10.1093/schbul/sbr084 Nuechterlein, 2008, Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment, Psychiatr Rehabil J, 31, 340, 10.2975/31.4.2008.340.349 Nuechterlein, 1992, Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress, Schizophr Bull, 18, 387, 10.1093/schbul/18.3.387 Ventura, 1998, Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P), Psychiatry Res, 79, 163, 10.1016/S0165-1781(98)00038-9 Bowie, 2008, Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: Differential sensitivity of clinical neuropsychological and experimental information processing tests, Schizophr Res, 106, 50, 10.1016/j.schres.2007.10.026 Harvey, 1999, Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients, Biol Psychiatry, 45, 32, 10.1016/S0006-3223(98)00273-X Selemon, 1995, Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17, Arch Gen Psychiatry, 52, 805, 10.1001/archpsyc.1995.03950220015005 Selemon, 1998, Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three-dimensional, stereologic counting method, J Comp Neurol, 392, 402, 10.1002/(SICI)1096-9861(19980316)392:3<402::AID-CNE9>3.0.CO;2-5 Lidow, 1994, A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex, Proc Natl Acad Sci U S A, 91, 4353, 10.1073/pnas.91.10.4353 Lidow, 1997, Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: Effects of chronic treatment with typical and atypical antipsychotic drugs, J Pharmacol Exp Ther, 283, 939 Seeman, 2010, Dopamine D2 receptors as treatment targets in schizophrenia, Clin Schizophr Relat Psychoses, 4, 56, 10.3371/CSRP.4.1.5 Jope, 2004, The glamour and gloom of glycogen synthase kinase-3, Trends Biochem Sci, 29, 95, 10.1016/j.tibs.2003.12.004 Beaulieu, 2011, The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol Rev, 63, 182, 10.1124/pr.110.002642 Azim, 2011, GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo, Glia, 59, 540, 10.1002/glia.21122 Flores, 2008, Constitutively active Akt induces enhanced myelination in the CNS, J Neurosci, 28, 7174, 10.1523/JNEUROSCI.0150-08.2008 Narayanan, 2009, Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination, J Neurosci, 29, 6860, 10.1523/JNEUROSCI.0232-09.2009 Keith, 2009, Use of long-acting risperidone in psychiatric disorders: Focus on efficacy, safety and cost-effectiveness, Expert Rev Neurother, 9, 9, 10.1586/14737175.9.1.9 O’Kusky, 1982, Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: A stereological analysis in normal and monocularly deprived animals, J Comp Neurol, 210, 307, 10.1002/cne.902100309 Uhlhaas, 2010, Neural synchrony and the development of cortical networks, Trends Cogn Sci, 14, 72, 10.1016/j.tics.2009.12.002 Szeligo, 1977, Response of the three main types of glial cells of cortex and corpus callosum in rats handled during suckling or exposed to enriched, control and impoverished environments following weaning, J Comp Neurol, 172, 247, 10.1002/cne.901720205 Diamond, 1972, Effects of environmental enrichment and impoverishment on rat cerebral cortex, J Neurobiol, 3, 47, 10.1002/neu.480030105 Braitenberg, 1962, A note on myeloarchitectonics, J Comp Neurol, 118, 141, 10.1002/cne.901180202